---
title: "Seelos Therapeutics (SEEL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SEEL.US/norm.md"
symbol: "SEEL.US"
name: "Seelos Therapeutics"
parent: "https://longbridge.com/en/quote/SEEL.US.md"
datetime: "2026-05-21T13:31:28.319Z"
locales:
  - [en](https://longbridge.com/en/quote/SEEL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SEEL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SEEL.US/norm.md)
---

# Seelos Therapeutics (SEEL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | 1.98 | -26.21 | -100.67 | -444.27 | -858.56 |
| ROE | -22.34% | 31.99% | 68.25% | -108.24% | 347.84% |
| Revenue | 376000.00 | 579000.00 | 653000.00 | 406000.00 | 336000.00 |
| Net income | 1.71M | -2.66M | -5.45M | 10.50M | -29.50M |

## Balance Sheet (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.38M | 3.61M | 5.42M | 6.22M | 11.89M |
| Leverage | -0.0846 | -0.1091 | -0.1617 | -0.2045 | -0.2520 |
| BVPS | -135.50 | -277.74 | -437.92 | -732.17 | -1458.83 |
| Turnover | 0.2823 | 0.1449 | 0.1564 | 0.0663 | 0.0354 |

## Cash Flow Statement (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -972000.00 | -4.64M | -1.91M | -5.75M | -5.90M |
| Investing CF | - | - | - | - | - |
| Financing CF | 742000.00 | 2.17M | 2.32M | 2.49M | -2.31M |
| Free CF | -3.31M | -4.55M | 2.15M | -28.49M | 13.88M |